Cendakimab Shows Promise in Phase II Trial for Atopic Dermatitis
Conexiant
July 17, 2024
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
News Staff
Affiliations:
Specialties:
Areas of Expertise: